Timea Berki Selected Research

Timea Berki Research Topics

Disease

4	Inflammation (Inflammations) 01/2022 - 08/2016
4	Multiple Sclerosis 12/2021 - 11/2010
4	Neoplasms (Cancer) 01/2021 - 03/2005
3	Ischemic Stroke 03/2019 - 08/2016
2	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 04/2009
2	Autoimmune Diseases of the Nervous System 01/2021 - 01/2016
2	Neuromyelitis Optica (Devic's Disease) 01/2021 - 01/2016
2	Chronic Hepatitis C 05/2020 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 12/2019 - 06/2011
2	Stroke (Strokes) 04/2018 - 08/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 04/2009
2	Hyperglycemia 08/2013 - 06/2002
2	Rheumatoid Arthritis 05/2009 - 01/2004
1	Fibrosis (Cirrhosis) 06/2022
1	Osteoarthritis 07/2021
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2020
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 12/2019
1	Disease Progression 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Infections 08/2016
1	Bronchopneumonia 01/2016
1	Encephalitis (Encephalitis, Rasmussen) 08/2014
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 08/2014
1	Seizures (Absence Seizure) 08/2014
1	Hallucinations (Hallucination) 08/2014
1	Glioma (Gliomas) 08/2014
1	Glucose Intolerance 08/2013
1	Hematologic Neoplasms (Hematological Malignancy) 06/2011
1	Multiple System Atrophy 11/2010
1	Rheumatic Diseases (Rheumatism) 04/2009
1	Necrosis 12/2006
1	Ankylosing Spondylitis 11/2006
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2006

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 01/2021 - 08/2006
5	AutoantibodiesIBA 01/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 03/2003
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 08/2013 - 03/2002
3	CytokinesIBA 01/2019 - 01/2013
3	GlucocorticoidsIBA 08/2013 - 03/2002
2	OsteopontinIBA 12/2021 - 06/2021
2	P-SelectinIBA 04/2018 - 08/2016
2	C-Reactive ProteinIBA 04/2018 - 11/2006
2	Hormones (Hormone)IBA 08/2006 - 03/2005
1	TOR Serine-Threonine KinasesIBA 06/2022
1	Hyaluronic Acid (Hyaluronan)IBA 07/2021
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 05/2020
1	Immune Checkpoint InhibitorsIBA 05/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	Keratin-18 (Keratin 18)IBA 03/2019
1	CaspasesIBA 03/2019
1	AntigensIBA 01/2019
1	Troponin T (Troponin T1)IBA 04/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2018
1	TroponinIBA 04/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2018
1	CD40 Ligand (CD40L)IBA 04/2018
1	symmetric dimethylarginineIBA 08/2016
1	Arginine (L-Arginine)FDA Link 08/2016
1	Interleukin-8 (Interleukin 8)IBA 08/2016
1	Interleukin-6 (Interleukin 6)IBA 08/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2016
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2016
1	SodiumIBA 08/2014
1	Insulin (Novolin)FDA Link 08/2013
1	Macrophage Migration-Inhibitory FactorsIBA 08/2013
1	Ribavirin (Virazole)FDA LinkGeneric 01/2013
1	TubulinIBA 11/2010
1	Protein Tyrosine PhosphatasesIBA 05/2009
1	EpitopesIBA 04/2009
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2009
1	trioctyl phosphine oxide (TOPO)IBA 04/2009
1	Amino Acids FDA Link 04/2009
1	AntioxidantsIBA 12/2006
1	Propidium (Propidium Iodide)IBA 12/2006
1	DeoxyriboseIBA 12/2006
1	Chalcone (Benzalacetophenone)IBA 12/2006
1	Sulfhydryl Compounds (Thiols)IBA 12/2006
1	Hydroxyl RadicalIBA 12/2006
1	E- 2- (4'- methylbenzylidene)- 1- benzusuberoneIBA 12/2006
1	FITC-annexin A5IBA 12/2006
1	Serotonin (5 Hydroxytryptamine)IBA 08/2006
1	Serotonin ReceptorsIBA 08/2006
1	Cytostatic AgentsIBA 02/2006
1	somatotropin releasing hormone receptorIBA 03/2005
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 03/2005

Therapy/Procedure

5	Therapeutics 01/2021 - 03/2002
2	Immunotherapy 01/2021 - 08/2014
1	Ligation 06/2022
1	Splenectomy 01/2022